The Scientist

» clinical trials and culture

Most Recent

image: Can Young Stem Cells Make Older People Stronger?

Can Young Stem Cells Make Older People Stronger?

By | December 11, 2017

Small trials using younger donors and elderly recipients hint that mesenchymal stem cell transfers might reduce frailty. 

0 Comments

The nine plaintiffs allege the university’s actions put women at risk.

0 Comments

The Good Pharma Scorecard finds some big pharmaceutical companies are meeting legal standards for disclosing results—but many studies still go unreported.

0 Comments

image: Antiviral Immunotherapy Comes of Age

Antiviral Immunotherapy Comes of Age

By | December 4, 2017

T-cell therapies are not just for cancer. Researchers are also advancing immunotherapy methods to protect bone marrow transplant patients from viral infections. 

0 Comments

image: Book Excerpt from <em>Jane on the Brain</em>

Book Excerpt from Jane on the Brain

By | December 1, 2017

In chapter 3, “The Sense of Sensibility,” author Wendy Jones uses scenes from one of Jane Austen’s most celebrated novels to illustrate the functioning of the body’s stress response system.

0 Comments

image: Sense, Sensibility, and Neuroscience

Sense, Sensibility, and Neuroscience

By | December 1, 2017

Jane Austen can teach us a lot about how our brains handle uncertainty.

0 Comments

image: Ten-Minute Sabbatical

Ten-Minute Sabbatical

By | December 1, 2017

Take a break from the bench to puzzle and peruse.

0 Comments

image: New CAR T-Cell Therapy Shows Promise in Trial for Leukemia

New CAR T-Cell Therapy Shows Promise in Trial for Leukemia

By | November 21, 2017

The immunotherapy, which targets CD22 on cancer cells rather than CD19, might prove useful in patients for whom previous T-cell treatments were unsuccessful. 

0 Comments

An open letter from hundreds of faculty members in the U.S. and abroad declares they won’t encourage students to pursue education or careers there.

2 Comments

image: Man Receives First In Vivo Gene-Editing Therapy

Man Receives First In Vivo Gene-Editing Therapy

By | November 15, 2017

The 44-year-old patient has Hunter syndrome, which doctors hope to treat using zinc finger nucleases.

0 Comments

Popular Now

  1. Can Young Stem Cells Make Older People Stronger?
  2. Thousands of Mutations Accumulate in the Human Brain Over a Lifetime
  3. Two Dozen House Republicans Do an About-Face on Tuition Tax
  4. CRISPR to Debut in Clinical Trials